Past exam of the biochemistry and Molecular Biology course of the University of Cambridge / 2025 / Paper 1 / Section B

RNA structure controls which ribosome-binding and decoding events are kinetically accessible. A bacterial messenger RNA can base-pair with itself or other RNA molecules, forming alternative structures whose populations depend on sequence, ligand concentration, temperature and translating ribosomes. Its sequence consequently encodes both a polypeptide and part of the mechanism controlling production of that polypeptide.

At initiation, a stem can sequester the Shine-Dalgarno sequence or start region, reducing pairing with the anti-Shine-Dalgarno region of the small-subunit ribosomal RNA and preventing productive initiation. Opening that structure makes the same coding sequence more accessible. Start-site accessibility also matters in bacteria whose transcripts do not use a canonical Shine-Dalgarno sequence; not all bacterial initiation can be reduced to this one motif. The regulatory variable is often competition between folding, unfolding and ribosome binding rather than a permanently closed structure.

A riboswitch couples a ligand-binding RNA domain to an expression platform that can alternatively expose or hide a translation-initiation region. Binding of a metabolite can stabilize one structure without requiring a separate regulatory protein. Direct binding of thiamine derivatives to bacterial messenger RNA established an RNA-based route to metabolic regulation.^[ref] In an RNA thermometer, heating destabilizes a stem and exposes the initiation site. The FourU thermometer provides a concrete example in which uridines help pair with the ribosome-binding region of a heat-responsive transcript.^[ref] Sequence specificity and a biologically relevant transition range distinguish such a sensor from the nonspecific fact that all RNA eventually denatures on heating.

Trans-acting small regulatory RNAs can remodel target messenger RNA structure by base pairing. Some block initiation directly, often aided by the RNA-binding chaperone Hfq; others disrupt an inhibitory stem and activate translation. Pairing can also expose an ribonuclease cleavage site or recruit degradation machinery. Protein-binding regulators provide another route: a ribosomal protein can recognize a structured element in its own polycistronic transcript and repress excess ribosomal-protein production. Occupancy of a structured site thus links translation to stoichiometric demand.

In a polycistronic messenger RNA, translation of an upstream coding region can unwind a structure masking a downstream initiation site, producing translational coupling. During elongation, the ribosome can unwind many structures, but a sufficiently resistant downstream RNA pseudoknot or stem, combined with an appropriate slippery sequence, can promote programmed ribosomal frameshifting. This changes the reading frame and hence the ratio of distinct protein products. Structure can also influence recoding or pause positions; a predicted stable hairpin alone does not establish that a physiologically meaningful pause occurs.

RNA structure further couples translation to transcription. In the tryptophan attenuation in bacterial gene regulation mechanism, rapid or stalled translation of a leader peptide changes which alternative RNA stems form. This decides formation of a transcription terminator and therefore how much downstream transcript is available. The immediate switch is termination of transcription, even though ribosome movement and structured RNA generate the decision. Likewise, intrinsic terminator formation, transcript degradation and ribosome protection change protein output without necessarily changing translation efficiency per intact transcript.

A convincing experiment measures both transcript abundance and protein output. Fuse the regulatory region to a reporter while retaining a control promoter; compare ligand or temperature conditions with a construct lacking the proposed structural element. A mutation disrupting one side of a stem, followed by a compensatory mutation restoring pairing with a changed sequence, distinguishes pairing from a single nucleotide-specific contact. RNA structure probing can test accessibility directly, and toeprinting can report initiation-complex occupancy. Include controls for reporter folding, growth, RNA half-life and effects of the perturbation on the ribosome itself. These tests connect a structural transition to the appropriate mechanistic step rather than assuming every change in protein abundance is a change in initiation.

A purified sample should be characterized along independent axes: identity, amount, chemical integrity, solution assembly, conformation and function. A high-resolution structural experiment cannot compensate for analysing the wrong protein or a mixture of molecular states. Conversely, useful biochemical information does not require an atomic structure.

First, verify identity and integrity. SDS-PAGE under reducing and nonreducing conditions estimates apparent subunit size and reveals many contaminants or disulfide-linked species. A single band cannot exclude a same-sized contaminant, a small chemical modification or several co-migrating oligomers. An immunoblot adds epitope recognition, while peptide mass spectrometry checks sequence-derived peptides and intact-mass analysis tests the overall molecular mass. Comparing measured and predicted masses can reveal cleavage, retained tags or modifications, but incomplete peptide coverage and heterogeneity constrain the inference. A tag-specific signal establishes the tag's presence rather than the identity of every residue.

Measure protein concentration using absorbance and an appropriate extinction coefficient, or a calibrated colorimetric assay with compatible standards. The Beer-Lambert law, $A=\epsilon lc$, converts absorbance to concentration only when the assumed molecular species and optical conditions apply. tryptophan residues, tyrosine residues and disulfides contribute to ultraviolet absorption; light scattering and nucleic-acid contamination can inflate readings. Buffer blanks, dilution linearity and a second quantification method help identify such problems. A concentration stated as monomer equivalents must not be confused with the concentration of oligomeric particles.

Next, determine whether the material is monodisperse and how it assembles in solution. Size-exclusion chromatography reports hydrodynamic size and can separate aggregates, but elution calibrated with globular standards gives an apparent size, not an absolute molecular mass for an elongated protein. SEC-MALS combines separation with multi-angle light scattering and a concentration detector to estimate the molar mass across the eluting peak; it can distinguish a large monomer from a compact oligomer when the detector models and sample composition are suitable.^[ref] Analytical ultracentrifugation supplies a complementary sedimentation-based approach, and concentration series can reveal reversible association. dynamic light scattering is sensitive to aggregates but is strongly influenced by a small number of large particles; a visually narrow intensity distribution is not a precise count of all molecular species.

Conformation and stability can then be assessed without determining an atomic model. Far-ultraviolet circular dichroism reports ensemble secondary-structure features, while near-ultraviolet circular dichroism and intrinsic aromatic fluorescence probe environments associated with tertiary packing. These signatures support folding and conformational changes but do not uniquely specify a three-dimensional fold. Thermal or chemical unfolding followed spectroscopically estimates stability only within an appropriate model: an irreversible aggregation-driven transition does not give an equilibrium folding free energy. Differential scanning calorimetry measures heat-capacity changes during a transition, and limited proteolysis can reveal exposed regions or stable domains. Buffer-only controls, matched concentrations and repeated heating–cooling cycles help separate reversible conformational change from precipitation.

Finally, test biological competence. For an enzyme, initial-rate measurements over substrate and enzyme concentration ranges establish specific activity and, where justified, Michaelis-Menten kinetics. For a binding protein, isothermal titration calorimetry can estimate binding stoichiometry, affinity and enthalpy, while a kinetic method such as surface plasmon resonance can resolve association and dissociation. Controls must include heat of dilution or nonspecific surface binding, ligand quality and the possibility of multivalent avidity. A measured dissociation constant does not by itself establish physiological function.

The methods should be chosen to answer a defined question and cross-check one another. For example, a clean gel, the expected intact mass, a single SEC-MALS species and concentration-independent native activity jointly support a useful preparation; none establishes complete homogeneity alone. Comparing fresh, stored and freeze–thawed samples identifies conditions suitable for later structural work. The resulting dossier should state what species is present under the actual experimental conditions and which features remain unresolved.

Directed evolution searches experimentally for useful sequences; rational design proposes changes from a mechanistic model. Their strengths are complementary. Both require a clear target phenotype and a reliable assay. “Improved” must mean improvement in a relevant property, such as catalytic efficiency in the intended solvent, rather than simply more expression or a larger reporter signal.

In directed evolution, a parent gene is diversified by error-prone PCR, recombination or targeted mutagenesis. Each variant must remain linked to the activity it encodes, for example in a separate bacterial clone or an appropriate display or compartmentalization system. A screening assay measures individual variants, whereas a selection assay allows successful variants preferential survival or recovery. Improved variants seed another cycle. Maintaining this genotype-phenotype linkage is essential: a diffusible product shared between cells could otherwise reward inactive neighbouring variants.

A classic example is evolution of subtilisin E for activity in dimethylformamide. Sequential random mutagenesis and screening found combinations of substitutions that improved performance in an environment outside the native enzyme's usual conditions. The result illustrates that useful mutations need not be obvious from the catalytic-site structure: they can alter stability, solvent interactions or the conformational ensemble.^[ref] To identify the reason for an improved clone, I would compare purified variants at equal active-enzyme concentration, measure activity and stability separately, and reconstruct individual and combined substitutions. Otherwise increased secretion, expression or resistance to the assay conditions could masquerade as altered intrinsic catalysis.

The advantages of directed evolution are that it can exploit effects too complicated to predict and optimize several coupled properties in the actual assay environment. Its limitations are experimental throughput, the availability of a starting activity and a faithful assay. The accessible sequence space is tiny relative to all possible proteins. Epistasis means that combining individually beneficial substitutions may fail, and a series of local improvements may miss a route requiring a temporarily deleterious intermediate. Selection on an easy surrogate substrate can improve the surrogate while failing on the intended substrate. A large library does not rescue an assay that measures the wrong property.

rational protein design instead uses sequence comparisons, structural information and chemical reasoning to propose changes. Examples include repositioning a catalytic group, reshaping a binding pocket, introducing a stabilizing interaction or removing a reactive surface residue. A focused set of site-directed mutagenesis is easier to interpret and cheaper to test than a vast random library when the relevant mechanism is understood. It can also create an initial active site for chemistry that the parent does not catalyse detectably. However, the accuracy of the proposal depends on treatment of folding, water, electrostatics, dynamics and the difference between substrate binding and transition-state stabilization.

Computational Kemp eliminase design provides a useful comparison with the subtilisin case. Designed active sites placed a base in a scaffold to promote proton abstraction in Kemp elimination, creating experimentally measurable catalytic activity. Subsequent directed evolution improved the designs, demonstrating that the initial geometric model captured useful chemistry but did not fully optimize the physical enzyme.^[ref] For a designed catalyst, controls should include the unmodified scaffold, removal of the proposed catalytic residue, no-enzyme reactions and direct product identification. A bound substrate, a plausible predicted structure or increased fluorescence from a reporter is not by itself evidence for the intended reaction mechanism.

A productive combined strategy uses rational knowledge to choose scaffolds and library positions, then lets directed evolution explore variants under the desired conditions. Sequencing and biophysical characterization of the successful variants can then improve the design model. Prediction focuses the search; controlled experiments decide whether the resulting protein actually has the desired function. Neither approach eliminates the need to assess trade-offs among activity, stability, specificity and manufacturability.